Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Eliminating oncogenic RAS: back to the future at the drawing board
Candy Laura Steffen, Pelin Kaya, Elisabeth Schaffner‐Reckinger, et al.
Biochemical Society Transactions (2023) Vol. 51, Iss. 1, pp. 447-456
Open Access | Times Cited: 19

Showing 19 citing articles:

RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectives
Dana Alawieh, Leila Cysique-Foinlan, Christophe Willekens, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 16
The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology
Kazem Nejati‐Koshki, Chris-Tiann Roberts, Ghader Babaei, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2683-2683
Open Access | Times Cited: 18
Identification of an H-Ras nanocluster disrupting peptide
Candy Laura Steffen, Ganesh babu Manoharan, Karolina Pavic, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 5
Synthetic gene circuits that selectively target RAS-driven cancers
Gabriel Senn, Leon Nissen, Yaakov Benenson
(2025)
Open Access
Synthetic gene circuits that selectively target RAS-driven cancers
Gabriel Senn, Leon Nissen, Yaakov Benenson
(2025)
Open Access
Evolution of computational techniques against various KRAS mutants in search for therapeutic drugs: a review article
Asif Mehmood, Mohammed Ageeli Hakami, Hanan A. Ogaly, et al.
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Closed Access
An overview of recent advancements in small molecules suppression of oncogenic signaling of K-RAS: an updated review
Ahmed Sabt, Haytham O. Tawfik, Eman F. Khaleel, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3
An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit KRAS Mutant Cancer Cell Growth
Pelin Kaya, Elisabeth Schaffner‐Reckinger, Ganesh babu Manoharan, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 8569-8584
Open Access | Times Cited: 3
Assessment of KRASG12C inhibitors for colorectal cancer
Gary A. Piazza, Preethi Chandrasekaran, Yulia Maxuitenko, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Roles of G proteins and their GTPase-activating proteins in platelets
Lorna O’Donoghue, Albert Smolenski
Bioscience Reports (2024) Vol. 44, Iss. 5
Open Access | Times Cited: 1
Reovirus infection of tumor cells reduces the expression of NKG2D ligands, leading to impaired NK-cell cytotoxicity and functionality
Raghad Khaleafi, Jelena Železnjak, Sapir Cordela, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Biophysical and Biochemical Characterization of Structurally Diverse Small Molecule Hits for KRAS Inhibition
Cynthia V. Pagba, Amit K. Gupta, K. M. Dilsha, et al.
ChemBioChem (2024) Vol. 25, Iss. 7
Closed Access
RAS isoform specific activities are disrupted by disease associated mutations during cell differentiation
Rohan Chippalkatti, Bianca Parisi, Farah Kouzi, et al.
European Journal of Cell Biology (2024) Vol. 103, Iss. 2, pp. 151425-151425
Open Access
Conclusions: the future of RAS drug discovery
Adrian L. Gill, Kevan M. Shokat
Elsevier eBooks (2024), pp. 497-504
Closed Access
Synthetic gene circuits that selectively target RAS-driven cancers
Gabriel Senn, Leon Nissen, Yaakov Benenson
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
RAS GTPases and Interleaflet Coupling in the Plasma Membrane
Junchen Liu, Neha Arora, Yong Zhou
Cold Spring Harbor Perspectives in Biology (2023) Vol. 15, Iss. 9, pp. a041414-a041414
Closed Access | Times Cited: 1
Discovery of Hit Compounds Targeting the P4 Allosteric Site of K-RAS, Identified through Ensemble-Based Virtual Screening
Patricia Gómez‐Gutierrez, J. Rubio, Juan J. Pérez
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 20, pp. 6412-6422
Open Access | Times Cited: 1
An improved PDE6D inhibitor combines with Sildenafil to synergistically inhibit KRAS mutant cancer cell growth
Pelin Kaya, Elisabeth Schaffner‐Reckinger, Ganesh babu Manoharan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Identification of an H-Ras nanocluster disrupting peptide
Ganesh babu Manoharan, Candy Laura Steffen, Karolina Pavic, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
RAS isoform specific activities are disrupted by disease associated mutations during cell differentiation
Rohan Chippalkatti, Bianca Parisi, Farah Kouzi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top